Keyphrases
Tumor Growth
100%
Angiogenesis
100%
Vascular Endothelial Growth Factor
100%
Neoalbaconol
100%
Tumor Angiogenesis
27%
Induced Apoptosis
9%
In Cancer
9%
Breast Cancer Cells
9%
Vascular Endothelial Growth Factor Receptor (VEGFR)
9%
Cancer Cells
9%
Proliferation Migration
9%
Anti-angiogenesis
9%
Receptor Activation
9%
Signal Transduction Pathway
9%
Anticancer Activity
9%
Suppression Effect
9%
Vascular Endothelial Cells
9%
Cell Apoptosis
9%
Human Umbilical Vein Endothelial Cells (HUVECs)
9%
Endothelial Cell Proliferation
9%
Breast Cancer Xenograft
9%
EGFR Overexpression
9%
Albatrellus Confluens
9%
Migration Invasion
9%
Angiogenic Factors
9%
Cancer Xenograft Model
9%
Factor Reduction
9%
Cascading Activation
9%
Direct Suppression
9%
Capillary-like Tube Formation
9%
EGFR Inhibition
9%
Inhibit Tumor
9%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Tumor Progression
100%
Vascular Endothelial Growth Factor
100%
Angiogenesis
100%
Cancer Cell
33%
Signal Transduction
16%
Cell Proliferation
16%
Antineoplastic Activity
16%
Antiangiogenic Activity
16%
VEGF Receptors
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Vasculotropin
100%
Epidermal Growth Factor Receptor
100%
Neoplasm
75%
Malignant Neoplasm
50%
Breast Cancer
50%
Vasculotropin Receptor
25%
Immunology and Microbiology
Vasculotropin
100%
Angiogenesis
100%
Cancer Cell
33%
Vascular Endothelial Cell
33%
Xenograft
16%
Antineoplastic Activity
16%
Cell Proliferation
16%
Antiangiogenic Activity
16%
Signal Transduction
16%
Capillary
16%